FIELD: medicine.
SUBSTANCE: according to the invention there is provided a hemostatic composition comprising gelatin and hyaluronic acid or its derivative, wherein the specified hyaluronic acid or its derivative is included in the specified composition with final content of at least 10% (wt/wt) and/or wherein the specified hyaluronic acid or its derivative is cross-linked by the exposure to dry heat at a temperature of 110°C to 200°C. According to the invention, there are provided methods of obtaining the said compositions and their application.
EFFECT: invention ensures reduced swelling, which allows safer sponge application, improved hemostatic properties and improved adhesive properties decreasing therethrough post-operation tissue bond.
74 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HAEMOSTATIC COMPOSITION CONTAINING HYALURONIC ACID | 2009 |
|
RU2486921C2 |
| HAEMOSTATIC SPRAYS AND COMPOSITIONS | 2005 |
|
RU2377022C9 |
| DRY HAEMOSTATIC COMPOSITION | 2013 |
|
RU2636240C2 |
| DRY COMPOSITION COMPRISING EXTRUSION ENHANCER | 2014 |
|
RU2678592C1 |
| HAEMOSTATIC SPONGE | 2011 |
|
RU2562569C2 |
| FAST-ACTING SEALING AND THE METHODS OF ITS APPLICATION AND PRODUCTION | 2007 |
|
RU2442612C2 |
| DRY COMPOSITION FOR USE IN HAEMOSTASIS AND WOUND HEALING | 2015 |
|
RU2715235C2 |
| APPLICATION HEMOSTATIC MATERIAL AND METHOD OF ITS PRODUCTION | 2020 |
|
RU2810165C1 |
| HAEMOSTASIS COMPOSITION INCLUDING A MATRIX BASED ON A CROSS-LINKING HYALURONIC ACID DERIVATIVE | 2017 |
|
RU2740191C2 |
| PROCOAGULANT PEPTIDES, THEIR DERIVATIVES AND THEIR APPLICATION | 2012 |
|
RU2635510C2 |
